Find uplifting stories about heroes, innovations, and solutions
10877 results for "lung disease treatment"
Scientists are developing better treatments for idiopathic pulmonary fibrosis, a deadly lung disease that kills most patients within five years. Understanding the genetic and environmental causes is finally leading to hope for the 3 million people affected worldwide.
A treatment for a rare bacterial lung infection just proved it can help patients much sooner than before. The drug, already approved for advanced cases, now shows real benefits when given to newly diagnosed patients.
Two companies are teaming up to manufacture medicines in orbit, where zero gravity could create more effective treatments for people with rare lung diseases. The first missions launch in 2026, bridging decades of space research with real patient benefits.
A world-first inhaled RNA therapy that targets the root cause of lung disease has entered human trials in Australia. The breakthrough could transform treatment for nine million Australians living with chronic lung conditions.
A breakthrough study from Sweden shows that giving extremely premature babies early hydrocortisone treatment dramatically increases their chances of surviving without lifelong lung disease. The simple, safe treatment could help thousands of the tiniest patients worldwide.
New targeted therapies and immunotherapies for lung cancer are now reaching over 60% of patients with advanced disease, a dramatic improvement in treatment access. Fifteen states have enacted laws requiring insurance coverage for biomarker testing that helps match patients to lifesaving treatments.
Scientists at Michigan State University discovered why a rare genetic lung condition makes it so hard for children to breathe, opening the door for future treatments. Using 3D imaging, they found excess muscle building up throughout the lungs, not just in blood vessels.
Japan has approved a groundbreaking new treatment for two deadly lung diseases, offering hope to thousands of patients who've had limited options for over ten years. The drug slows lung function decline and could transform how doctors treat these life-threatening conditions.
For 40 years, treating a rare genetic lung disease meant weekly IV infusions at a clinic. Now a pill that blocks 90% of the damaging enzyme just secured a nearly half-billion dollar deal to reach American patients.
Scientists discovered a genetic link that could finally explain why some people develop a deadly lung disease. A breakthrough drug tested in mice offers hope for millions living with idiopathic pulmonary fibrosis.
A groundbreaking injection just got approved for NHS use in England and Wales, offering fresh hope to 30,000 people struggling with severe COPD. This marks the first biologic therapy available for uncontrolled chronic lung disease after years of limited innovation.
A new experimental drug from biotech company Roivant just achieved remarkable results in treating a serious form of pulmonary hypertension, opening doors to better treatments for patients struggling with this dangerous lung condition. The Phase 2 study showed the drug significantly improved blood flow, breathing ability, and heart health markers.
Families fighting Huntington's disease celebrated a breakthrough this Valentine's Day as researchers announced the first treatment for the deadly brain condition. The discovery brings renewed hope to a community that has waited decades for medical progress.
Families facing Alexander disease, a rare and devastating neurological disorder, now have hope after the FDA approved the first-ever treatment for the condition. The new drug showed remarkable results in helping both children and adults walk better and maintain motor skills.
A new targeted therapy for a rare form of lung cancer just earned priority review from the FDA, potentially offering hope to thousands of patients who currently have limited treatment options. The drug specifically targets HER2 mutations found in about 2-4% of lung cancer cases.
University of Edinburgh researchers discovered how immune cells trigger debilitating scar tissue in Crohn's disease patients, opening the door for treatments that could prevent the condition's most challenging complication. The breakthrough could help millions avoid surgery and transform lives.
A California space company just partnered with a major pharmaceutical firm to manufacture impossible-to-make drugs in orbit. The collaboration could unlock breakthrough treatments for rare lung diseases by 2026.
For the first time ever, children and adults with Alexander disease have a treatment that attacks the root cause of their condition, not just the symptoms. The FDA's approval of zilganersen gives hope to families facing a disease that has always been fatal.
A powerful new combination therapy just gained approval to help patients fighting an aggressive form of lung cancer live longer. The treatment offers hope for thousands diagnosed with extensive-stage small cell lung cancer each year.
Scientists have discovered that a cancer treatment called CAR T-cell therapy can stop autoimmune diseases like lupus and multiple sclerosis without the dangerous side effects. Hundreds of patients are already experiencing remarkable recoveries, and the first treatments could be approved next year.
Showing 20 of 10877